Table 2.
CRDs, no. (%) | AF (n = 55) | Non-AF (n = 49) | p Value |
---|---|---|---|
Asthma | 10 (18.2) | 6 (12.2) | 0.402 |
COPD | 14 (25.5) | 12 (24.5) | 0.908 |
Bronchiectasis | 4 (7.3) | 3 (6.1) | 0.815 |
Lung cancer | 5 (9.1) | 3 (6.1) | 0.578 |
Lung fibrosis | 10 (16.4) | 2 (4.1) | 0.025 |
Sarcoidosis | 1 (1.8) | 0 (0) | 0.343 |
Chronic rhinosinusitis | 2 (3.6) | 0 (0) | 0.178 |
Pneumoconiosis | 1 (1.8) | 0 (0) | 0.343 |
Hypersensitivity pneumonitis | 0 (0) | 1 (2.0) | 0.287 |
Chronic pleural diseases | 2 (3.6) | 0 (0) | 0.178 |
Sleep apnea syndrome | 0 (0) | 0 (0) | 1.000 |
CRDs: chronic respiratory diseases; AF: Aspergillus fumigatus; COPD: chronic obstructive pulmonary disorders.
aLung fibrosis was significantly more prevalent in AF group than in non-AF group (p = 0.025).